RESULTS OF A NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN MEDOXOMIL, IN PATIENTS WITH PRIMARY HYPERTENSION

被引：1
|
作者：
Bakris, G. [1 ]
Sica, D. [2 ]
Weber, M. [3 ]
White, W. B. [4 ]
Perez, A. [5 ]
Cao, C. [5 ]
Kupfer, S. [5 ]
机构：
[1] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[2] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA
[3] SUNY Downstate Coll Med, New York, NY USA
[4] Univ Connecticut, Sch Med, Farmington, CT USA
[5] Takeda Global Res & Dev, Deerfield, IL USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000379505.93273.55
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E429 / E429
页数：1
相关论文
共 50 条
  • [1] Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
    Barrios, Vivencio
    Escobar, Carlos
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (16) : 2249 - 2261
  • [2] Azilsartan Medoxomil: A New Angiotensin Receptor Blocker
    Zaiken, Kathy
    Cheng, Judy W. M.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1577 - 1589
  • [3] EFFICACY AND SAFETY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN-MEDOXOMIL, IN KOREAN PATIENTS WITH ESSENTIAL HYPERTENSION
    Juhasz, Attila
    Wu, Jingtao
    Hisada, Michie
    Tsukada, Tomoka
    Jeong, Myung Ho
    JOURNAL OF HYPERTENSION, 2016, 34 : E84 - E85
  • [4] Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
    Juhasz A.
    Wu J.
    Hisada M.
    Tsukada T.
    Jeong M.H.
    Clinical Hypertension, 24 (1)
  • [5] Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension
    Johnson, Wallace
    White, William B.
    Sica, Domenic
    Bakris, George L.
    Weber, Michael A.
    Handley, Alison
    Perez, Alfonso
    Cao, Charlie
    Kupfer, Stuart
    Saunders, Elijah B.
    JOURNAL OF CLINICAL HYPERTENSION, 2017, 19 (07): : 695 - 701
  • [6] ANTIHYPERTENSIVE EFFICACY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL IN COMBINATION WITH AMLODIPINE
    Weber, M. A.
    White, W. B.
    Sica, D.
    Bakris, G. L.
    Perez, A.
    Cao, C.
    Kupfer, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E279 - E280
  • [7] Improved Process for Azilsartan Medoxomil: A New Angiotensin Receptor Blocker
    Radl, Stanislav
    Cerny, Josef
    Stach, Jan
    Gablikova, Zuzana
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2013, 17 (01) : 77 - 86
  • [8] NEW ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL: COMPARISON TO VALSARTAN
    Sica, D.
    White, W. B.
    Weber, M. A.
    Bakris, G. L.
    Perez, A.
    Cao, C.
    Kupfer, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E276 - E276
  • [9] EFFECTS OF AZILSARTAN MEDOXOMIL COMPARED TO OTHER ANGIOTENSIN II RECEPTOR BLOCKER ON PLASMA ALDOSTERONE LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION
    Okamoto, Shinya
    Iwasaki, Hitoshi
    Dohi, Kaoru
    Okamoto, Ryuuji
    Fujii, Eitarou
    Yamada, Norikazu
    Itou, Masaaki
    JOURNAL OF HYPERTENSION, 2016, 34 : E412 - E412
  • [10] Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
    Hjermitslev, Marie
    Grimm, Daniela G.
    Wehland, Markus
    Simonsen, Ulf
    Krueger, Marcus
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (04) : 225 - 233
12345